FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
- £225.44m
- £227.66m
RCS - Faron Pharma. Oy - Founders named European Inventor Award finalists
AnnouncementREG - Faron Pharma. Oy - Update on financial status
AnnouncementREG - Faron Pharma. Oy - Board Change
AnnouncementRCS - Faron Pharma. Oy - Faron confirms plans under new leadership
AnnouncementREG - Faron Pharma. Oy - Appointment of Chief Financial Officer
AnnouncementREG - AIM - AIM Notice - 09/04/2024
AnnouncementREG - Faron Pharma. Oy - Decisions of the Board of Directors
AnnouncementREG - Faron Pharma. Oy - Approval of Warrant Terms and Conditions
AnnouncementREG - Faron Pharma. Oy - Appointment of Chief Executive Officer
AnnouncementREG - Faron Pharma. Oy - Results of the Annual General Meeting
AnnouncementREG - Faron Pharma. Oy - Announcement of Placing
AnnouncementREG - Faron Pharma. Oy - Issue of Warrants to IPF Funding Update
AnnouncementREG - Faron Pharma. Oy - Faron´s Annual Report 2023
AnnouncementREG - Faron Pharma. Oy - Additional Positive Data from Phase 1 of BEXMAB
AnnouncementRCS - Faron Pharma. Oy - Faron to Host BEXMAB Webcast
AnnouncementREG - Faron Pharma. Oy - Notice of Annual General Meeting 2024
AnnouncementREG - Faron Pharma. Oy - Financial Statement January 1 to December 31 2023
AnnouncementREG - Faron Pharma. Oy - Binding commitments for convertible loans
AnnouncementREG - Faron Pharma. Oy - Update to Faron’s Financial Calendar for 2024
Announcement